If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
380.00    30.00 (8.57%)
Bid:
370.00
Ask:
390.00
Spread: 20.00 (5.405%)
Market Cap: £36.31m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

AGM Trading Update

3 Sep 2025 07:00

RNS Number : 7080X
Cropper(James) PLC
03 September 2025
 

3 September 2025

 

 

James Cropper plc

("James Cropper", the "Company" or the "Group")

 

AGM Trading Update

 

James Cropper plc, the Advanced Materials and Paper & Packaging group, provides a trading update for the 18-week period ended 2 August 2025 ("the Period"), ahead of its Annual General Meeting taking place at 11:30am today.

 

Performance in the Period has been slightly ahead of expectations in both divisions with good progress in the execution of the Board's updated strategy, outlined at the Capital Markets Event on 18 June 2025. With disciplined cash management in line with our recently stated capital allocation policy, and the benefit of £1.2m net receipts from the sale of non-core assets, net debt of £10.3m as at 2 August 2025 has reduced from £12.9m since 29 March 2025 ("FY25"), the end of the Group's last financial year, and is £5.0m lower than the position at the same time last year.

 

The Board is confident in the performance of the Group for the full year ending in March 2026, with the Group targeting significant growth in Adjusted EBITDA against FY25. The roll out of our revised strategy is proceeding as planned with expectations of improved mid-term prospects of both the Advanced Materials and Paper & Packaging businesses.

 

David Stirling, CEO, stated:

 

"I am pleased we are making progress on our three key objectives: sales growth in Advanced Materials, improving profitability in Paper & Packaging and disciplined cash management to embed leverage below 2x EBITDA. The business is becoming more agile and streamlined to deliver our objectives, which will create long-term value for shareholders as we make progress against our recently introduced strategy."

 

-ENDS-

Enquiries:

 

James Cropper plc

David Stirling, Chief Executive Officer

Andrew Goody, Chief Financial Officer

 

Tel: +44(0)1539 722002

 

Shore Capital - Nominated Adviser and Broker

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

 

Tel: +44 (0)207 408 4090

 

IFC Advisory - Financial PR

Graham Herring, Tim Metcalfe, Zach Cohen

 

Tel: +44 (0) 203 934 6630

james.cropper@investor-focus.co.uk

About James Cropper plc

James Cropper plc is globally recognised for its specialist capabilities in the design and manufacture of advanced materials and paper products. Operating through two principal businesses - Advanced Materials and Paper & Packaging - and built upon 180 years of innovation, the Group serves a diverse range of customers with high-performance solutions tailored to specialised applications.

 

The Advanced Materials business develops cutting-edge nonwoven materials and electrochemical coatings for sectors including aerospace, clean energy, and defence. The Paper & Packaging business offers premium creative papers and bespoke moulded fibre packaging together with leading recycled-fibre capabilities and products, supporting the transition to a circular economy.

 

Headquartered in Burneside (UK), with additional manufacturing sites in Crewe (UK), Launceston (UK), and Schenectady (USA), James Cropper leverages deep expertise in material science and longstanding partnerships with industry-leading businesses and brands to develop bespoke solutions that meet complex technical and aesthetic specifications.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBUGDCLBGDGUD
Date   Source Headline
9th Aug 20197:00 amRNSNotification of Transaction of PDMR
8th Aug 20197:00 amRNSDirectors' Dealings
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
2nd Aug 201912:27 pmRNSGrant of Awards under Long Term Incentive Plan
1st Aug 20199:30 amRNSResult of AGM
31st Jul 201911:00 amRNSAGM Statement and Trading Update
25th Jul 20197:00 amRNSDirectorate Change
22nd Jul 201912:11 pmRNSDirector/PDMR Shareholding
22nd Jul 201910:35 amRNSReplacement - Director/PDMR Shareholding
19th Jul 20198:40 amRNSDirector/PDMR Shareholding
18th Jul 201912:40 pmRNSDirector/PDMR Shareholding
17th Jul 201910:44 amRNSDirector/PDMR Shareholding
11th Jul 20198:30 amRNSDirector/PDMR Shareholding
10th Jul 20199:15 amRNSNotice of AGM and change of website address
25th Jun 20197:00 amRNSFinal Results
20th Jun 201910:02 amRNSChange of Adviser
24th May 201910:56 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
22nd Mar 20197:00 amRNSDirector/PDMR Shareholding
20th Mar 20197:00 amRNSDirector/PDMR Shareholding
19th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 20197:00 amRNSDirector/PDMR Shareholding
1st Mar 20197:46 amRNSDirector/PDMR Shareholding
27th Feb 20197:00 amRNSDirector/PDMR Shareholding
20th Feb 20197:00 amRNSIssue of Equity
15th Feb 20197:00 amRNSDirector/PDMR Shareholding
28th Jan 201910:05 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Dec 20181:59 pmRNSDirector/PDMR Shareholding
13th Dec 20187:00 amRNSIssue of Equity and Director's Dealings
6th Dec 20187:00 amRNSDirector/PDMR Shareholding
3rd Dec 201812:37 pmRNSIssue of Equity
21st Nov 20181:03 pmRNSHolding(s) in Company
21st Nov 201810:58 amRNSDirector/PDMR Shareholding
13th Nov 20187:00 amRNSHalf-year Report
5th Oct 20182:39 pmRNSDirector/PDMR Shareholding
1st Oct 20189:39 amRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSDirector/PDMR Shareholding
26th Sep 20187:00 amRNSIssue of Equity and PDMR Transactions
24th Sep 20187:00 amRNSDirector/PDMR Shareholding
19th Sep 20183:32 pmRNSDirector/PDMR Shareholding
18th Sep 20182:00 pmRNSTrading Update
11th Sep 20182:40 pmRNSDirector/PDMR Shareholding
20th Aug 20187:45 amRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSGrants under Long Term Incentive Plan
6th Aug 20189:41 amRNSDirector/PDMR Shareholding
3rd Aug 20189:36 amRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
1st Aug 20187:00 amRNSDirector Appointment
31st Jul 20181:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.